Factoring in new gene therapy treatments for hemophilia A

    loading  Checking for direct PDF access through Ovid

Abstract

Delivery of a modified factor VIII gene leads to dramatic improvement of severe hemophilia A in human trials.

Related Topics

    loading  Loading Related Articles